465 related articles for article (PubMed ID: 31595495)
1. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
2. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
3. LncRNAs: emerging biomarkers in gastric cancer.
Gu Y; Chen T; Li G; Yu X; Lu Y; Wang H; Teng L
Future Oncol; 2015; 11(17):2427-41. PubMed ID: 26289363
[TBL] [Abstract][Full Text] [Related]
4. Roles of long noncoding RNAs in gastric cancer and their clinical applications.
Sun W; Yang Y; Xu C; Xie Y; Guo J
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2231-7. PubMed ID: 27246953
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375.
Quan Y; Zhang Y; Lin W; Shen Z; Wu S; Zhu C; Wang X
Biochem Biophys Res Commun; 2018 Mar; 497(2):527-534. PubMed ID: 29428732
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs: novel insights into gastric cancer.
Fang XY; Pan HF; Leng RX; Ye DQ
Cancer Lett; 2015 Jan; 356(2 Pt B):357-66. PubMed ID: 25444905
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
10. Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
Chen W; Feng Z; Huang J; Fu P; Xiong J; Cao Y; Liu Y; Tu Y; Li Z; Jie Z; Xiao T
Dis Markers; 2021; 2021():7724997. PubMed ID: 34394774
[TBL] [Abstract][Full Text] [Related]
11. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
Li C; Liang G; Yao W; Sui J; Shen X; Zhang Y; Ma S; Ye Y; Zhang Z; Zhang W; Yin L; Pu Y
Oncol Rep; 2016 Mar; 35(3):1529-40. PubMed ID: 26718650
[TBL] [Abstract][Full Text] [Related]
12. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
14. An Updated Review on the Therapeutic, Diagnostic, and Prognostic Value of Long Non-Coding RNAs in Gastric Cancer.
Mohammadzadeh A; Dastmalchi N; Hussen BM; Shadbad MA; Safaralizadeh R
Curr Med Chem; 2022; 29(19):3471-3482. PubMed ID: 34781858
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs expression in gastric cancer.
Esfandi F; Taheri M; Kholghi Oskooei V; Ghafouri-Fard S
J Cell Biochem; 2019 Aug; 120(8):13802-13809. PubMed ID: 30938855
[TBL] [Abstract][Full Text] [Related]
16. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of long noncoding RNAs on gastric cancer.
Li T; Mo X; Fu L; Xiao B; Guo J
Oncotarget; 2016 Feb; 7(8):8601-12. PubMed ID: 26788991
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.
Yuan L; Xu ZY; Ruan SM; Mo S; Qin JJ; Cheng XD
Mol Cancer; 2020 May; 19(1):96. PubMed ID: 32460771
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
[TBL] [Abstract][Full Text] [Related]
20. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
